The SSF is happy to announce that yesterday the U.S. House of Representatives passed the Health Care Cost Act under the Affordable Care Act (ACA). This legislation includes a provision repealing limitations on the purchase of over-the counter (OTC) medications from health saving accounts (HSAs) and flexible spending arrangements (FSAs) unless there was an accompanying prescription from a doctor.
In April, Steven Taylor, SSF CEO, testified before the Subcommittee on Oversight of the House Committee on Ways and Means hearing about how the legislation’s limitations on the use of OTC medications impact Sjögren’s patients.
The SSF was proud to speak on behalf of the millions of Sjögren’s patients in America and was the only patient group represented at the hearing. We want to thank everyone who responded to our email asking how OTC medications affect your daily lives. Yesterday’s vote shows that, together, we can make a difference and conquer Sjögren’s!
The SSF will continue to make advocacy that improves the lives of Sjögren’s patients a priority and be a presence on Capitol Hill. In case you missed Taylor’s testimony, you can watch the video below. Thank you again for supporting the SSF and our mission.